Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-30 @ 3:37 PM
Study NCT ID:
NCT01214733
Status:
COMPLETED
Last Update Posted:
2015-12-02
First Post:
2010-10-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of RoActemra/Actemra (Tocilizumab) Plus DMARDs in Patients With Rheumatoid Arthritis
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-05
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-04
First Submit QC Date:
None
Study First Post Date:
2010-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-12-01
Last Update Post Date:
2015-12-02
Last Update Post Date Type:
ESTIMATED